Five-Year Survival Following Hepatic Resection After Neoadjuvant Therapy for Nonresectable Colorectal [Liver] Metastases

By R. Adam, E. Avisar, A. Ariche, S. Giachetti, D. Azoulay, D. Castaing, F. Kunstlinger, Francis Levi, F. Bismuth. Annals of Surgical Oncology, 2001

614 citations recorded by the source corpus.

Subfields: Hepatology, Surgery

View Paper: https://www.semanticscholar.org/paper/d60df7381f144939cd6b01d43dd9e97e2197c076

Citations in the corpus

• Tumor Progression While on Chemotherapy: A Contraindication to Liver Resection for Multiple Colorectal Metastases? (2004, background): “These higher response rates have played a key role in improving the resectability of hepatic metastases, allowing 15% to 20% of patients with initially unresectable tumors to be secondarily resected with reported 5-year survival rates of 30% to 40%.(18,19) Irrespective of their initial resectability”